741254-28-4 Usage
Uses
Used in Pharmaceutical Industry:
(3-Ethoxycarbonylaminophenyl)acetic acid is used as a potential therapeutic agent for [specific diseases or conditions] due to its [pharmacological properties or mechanisms of action]. Its molecular structure and functional groups allow for interactions with biological targets, making it a promising candidate for the development of new drugs.
Used in Chemical Industry:
(3-Ethoxycarbonylaminophenyl)acetic acid is used as a precursor for synthesizing other compounds in the chemical industry. Its unique molecular structure and functional groups enable it to serve as a building block for creating new chemical entities with diverse applications.
Further studies and experimentation are required to explore the additional properties and applications of (3-Ethoxycarbonylaminophenyl)acetic acid, which may lead to the discovery of novel uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 741254-28-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,1,2,5 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 741254-28:
(8*7)+(7*4)+(6*1)+(5*2)+(4*5)+(3*4)+(2*2)+(1*8)=144
144 % 10 = 4
So 741254-28-4 is a valid CAS Registry Number.
741254-28-4Relevant articles and documents
Synthesis of pyrazole, isoxazole, and aminopyrimidine ring-fused benzothiocycloheptane-derived oxazolidinones and their corresponding sulfone derivatives
Khlebnikov, Vladimir,Maiti, Samarendra N.,Vara Prasad,Boyer, Frederick E.,Stier, Mike
, p. 3858 - 3862 (2008/09/17)
The synthesis of a series of pyrazole, isoxazole, and aminopyrimidine ring-fused benzothiocycloheptane-derived oxazolidinones and their corresponding sulfone derivatives is described. Georg Thieme Verlag Stuttgart.
OXAZOLIDINONE DERIVATES N-SUBSTITUTED BY A TRICYCLIC RING, FOR USE AS ANTIBACTERIAL AGENTS
-
Page/Page column 80-81, (2010/02/08)
Compounds of formula (I) and methods for their preparation are disclosed. Further disclosed are methods of making biologically active compounds of formula (I) as well as pharmaceutically acceptable compositions comprising compounds of formula (I). Compounds of formula (I) as disclosed herein can be used in a variety of applications including use as antibacterial P is a tricyclic ring system as defined in claiml.
